Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and Treatment.

Microorganisms · 2025 · PMC12029526 · PMID 40284559

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These findings collectively suggest that targeting non-coding RNA, including miRNA and lncRNA, may be significant for advancing RNA-based therapies in treating MDR-TB.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.